Palisade BioPALI
13F holders, Q4 2024 (December 31)10holders +1
2new positions
1sold out
$1.65avg. 13F price*
At the end of Q4 2024, 10 institutions reported holding Palisade Bio Inc. (PALI) in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($174K), Cetera Investment Advisers ($116K) and Marex Group Ltd ($59K).
- Company
- Palisade Bio Inc.
- CUSIP
- 696389402
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $132K |
| Exits | 1 | $29K |
All 13F filers, Q3 2024 → Q4 2024: 145,458 shares bought and 8,333 shares sold, net +137,125 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Armistice Capital, LLC | 0.00% | Add +102.6% | 105,367 | $174K |
| Cetera Investment Advisers | 0.00% | New | 70,006 | $116K |
| Marex Group Ltd | 0.00% | No change | 35,759 | $59K |
| Geode Capital Management, LLC | 0.00% | New | 10,052 | $17K |
| UBS Group AG | 0.00% | Add +28848.4% | 8,974 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +193.4% | 4,686 | $8K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 100 | $165 |
| Wells Fargo & Company | 0.00% | No change | 21 | $35 |
| Bank of America Corp. | 0.00% | Add +11.1% | 10 | $16 |
| Morgan Stanley | 0.00% | Reduce -95.0% | 7 | $12 |
"% of holder's portfolio" is PALI's weight in each manager's 13F, not the share of Palisade Bio Inc. the manager owns.